Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Japanese physicians' attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines.

Katsuta T, Moser CA, Offit PA, Feemster KA.

Papillomavirus Res. 2019 Jun;7:193-200. doi: 10.1016/j.pvr.2019.04.013. Epub 2019 Apr 30.

2.

Principal Controversies in Vaccine Safety in the United States.

DeStefano F, Bodenstab HM, Offit PA.

Clin Infect Dis. 2019 Feb 12. doi: 10.1093/cid/ciz135. [Epub ahead of print]

PMID:
30753348
3.

Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines.

Plotkin SA, Offit PA, Reiss D.

Pediatr Infect Dis J. 2018 Dec;37(12):e353. doi: 10.1097/INF.0000000000002210. No abstract available.

PMID:
30408015
4.

Challenges to Developing a Rotavirus Vaccine.

Offit PA.

Viral Immunol. 2018 Mar;31(2):104-108. doi: 10.1089/vim.2017.0121. Epub 2017 Dec 21. Review.

PMID:
29265955
5.

Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.

Katsuta T, Miyaji Y, Offit PA, Feemster KA.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):380-385. doi: 10.1093/jpids/pix063. Review.

PMID:
28992265
6.

Why Aren't International Travelers Vaccinated for Measles?

Handy LK, Offit PA.

Ann Intern Med. 2017 Jul 18;167(2):127-128. doi: 10.7326/M17-1044. Epub 2017 May 16. No abstract available.

PMID:
28505661
7.

Vaccines and autism in primate model.

Offit PA.

Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12236-7. doi: 10.1073/pnas.1516574112. Epub 2015 Sep 28. No abstract available.

8.

Vaccine Exemptions: When Do Individual Rights Trump Societal Good?

Offit PA.

J Pediatric Infect Dis Soc. 2015 Jun;4(2):89-90. doi: 10.1093/jpids/piv018. Epub 2015 Apr 9. No abstract available.

PMID:
26407405
9.

A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study.

Williams SE, Rothman RL, Offit PA, Schaffner W, Sullivan M, Edwards KM.

Acad Pediatr. 2013 Sep-Oct;13(5):475-80. doi: 10.1016/j.acap.2013.03.011.

10.

Incomplete financial disclosure in a viewpoint on complementary and alternative therapies.

Offit PA.

JAMA. 2012 Aug 1;308(5):454. doi: 10.1001/jama.2012.7751. No abstract available.

PMID:
22851106
11.

Should childhood vaccination be mandatory? Yes.

Offit PA.

BMJ. 2012 May 15;344:e2434. doi: 10.1136/bmj.e2434. No abstract available.

PMID:
22589519
12.

Studying complementary and alternative therapies.

Offit PA.

JAMA. 2012 May 2;307(17):1803-4. doi: 10.1001/jama.2012.518. No abstract available. Erratum in: JAMA. 2012 Aug 1;308(5):456.

PMID:
22550193
13.

Influence of potential protective mechanisms on the development of live rotavirus vaccines.

Ward RL, Clark HF, Offit PA.

J Infect Dis. 2010 Sep 1;202 Suppl:S72-9. doi: 10.1086/653549. Review.

PMID:
20684721
14.

Vaccines and autism: a tale of shifting hypotheses.

Gerber JS, Offit PA.

Clin Infect Dis. 2009 Feb 15;48(4):456-61. doi: 10.1086/596476. Review.

15.

The problem with Dr Bob's alternative vaccine schedule.

Offit PA, Moser CA.

Pediatrics. 2009 Jan;123(1):e164-9. doi: 10.1542/peds.2008-2189. Review.

PMID:
19117838
16.

New book about vaccine safety.

Offit PA.

Pediatrics. 2008 Oct;122(4):871-2. doi: 10.1542/peds.2008-2275. Review. No abstract available.

PMID:
18829814
17.

Vaccines and autism revisited--the Hannah Poling case.

Offit PA.

N Engl J Med. 2008 May 15;358(20):2089-91. doi: 10.1056/NEJMp0802904. No abstract available.

18.

Thimerosal and vaccines--a cautionary tale.

Offit PA.

N Engl J Med. 2007 Sep 27;357(13):1278-9. No abstract available.

19.

Rotavirus vaccines: round two.

Offit PA.

Hum Vaccin. 2006 Mar-Apr;2(2):84-5. Epub 2006 Mar 17. No abstract available.

PMID:
17012884
20.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Clark HF, Offit PA, Plotkin SA, Heaton PM.

Pediatr Infect Dis J. 2006 Jul;25(7):577-83. Review.

PMID:
16804425
21.

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.

Vaccine. 2006 May 29;24(22):4821-9. Epub 2006 Mar 31.

PMID:
16621194
22.

RotaTeq: a pentavalent bovine--human reassortant rotavirus vaccine.

Offit PA, Clark HF.

Pediatr Ann. 2006 Jan;35(1):29-34. Review. No abstract available.

PMID:
16466073
23.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

N Engl J Med. 2006 Jan 5;354(1):23-33.

24.

Why are pharmaceutical companies gradually abandoning vaccines?

Offit PA.

Health Aff (Millwood). 2005 May-Jun;24(3):622-30.

PMID:
15886152
25.

The Cutter incident, 50 years later.

Offit PA.

N Engl J Med. 2005 Apr 7;352(14):1411-2. No abstract available.

PMID:
15814877
26.

Vaccines for rotavirus gastroenteritis universally needed for infants.

Clark HF, Offit PA.

Pediatr Ann. 2004 Aug;33(8):536-43.

PMID:
15354605
27.

Meningococcal conjugate vaccine in the UK: an update.

Offit PA, Peter G.

Lancet. 2004 Jul 24-30;364(9431):309-10. No abstract available.

PMID:
15276371
28.

Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.

Ward RL, Bernstein DI, Smith VE, Sander DS, Shaw A, Eiden JJ, Heaton P, Offit PA, Clark HF.

J Infect Dis. 2004 Jun 15;189(12):2290-3. Epub 2004 May 25.

PMID:
15181577
29.

Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.

Clark HF, Lawley D, Shrager D, Jean-Guillaume D, Offit PA, Whang SY, Eiden JJ, Bennett PS, Kaplan KM, Shaw AR.

Pediatr Infect Dis J. 2004 Mar;23(3):206-11.

PMID:
15014293
30.

The meningococcal vaccine--public policy and individual choices.

Offit PA, Peter G.

N Engl J Med. 2003 Dec 11;349(24):2353-6. No abstract available.

PMID:
14668463
31.
32.

Communicating science to the public: MMR vaccine and autism.

Offit PA, Coffin SE.

Vaccine. 2003 Dec 8;22(1):1-6. Review.

PMID:
14604564
33.

The power of 'box a'.

Offit PA.

Expert Rev Vaccines. 2003 Feb;2(1):1-3. No abstract available.

PMID:
12901590
34.

Determination of efficiency of attachment of biotinylated antibodies to avidin-linked, aqueous-based microcapsules by flow cytometry.

Chow AA, Moser CA, Speaker TJ, Offit PA.

J Immunol Methods. 2003 Jun 1;277(1-2):135-9.

PMID:
12799046
35.

Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases?

Offit PA, Hackett CJ.

Pediatrics. 2003 Mar;111(3):653-9. Review.

PMID:
12612250
36.

Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

Cetron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, Barwick RS, Weld LH, Chen R, Clover RD, Deseda-Tous J, Marchessault V, Offit PA, Monath TP.

MMWR Recomm Rep. 2002 Nov 8;51(RR-17):1-11; quiz CE1-4.

37.

The future of rotavirus vaccines.

Offit PA.

Semin Pediatr Infect Dis. 2002 Jul;13(3):190-5. Review.

PMID:
12199615
38.

Specific attachment of aqueous-based microcapsules to macrophages, B cells, and dendritic cells in vitro.

Brubaker JO, Macartney KK, Speaker TJ, Offit PA.

J Microencapsul. 2002 Mar-Apr;19(2):213-23.

PMID:
11837976
39.

Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?

Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S.

Pediatrics. 2002 Jan;109(1):124-9. Review.

PMID:
11773551
40.
41.

How vaccine safety is monitored before and after licensure.

Macartney KK, Offit PA.

Pediatr Ann. 2001 Jul;30(7):392-9. No abstract available.

PMID:
11469170
42.

Correlates of protection against rotavirus infection and disease.

Offit PA.

Novartis Found Symp. 2001;238:106-13; discussion 114-24. Review.

PMID:
11444023
43.

B2 but not B1 cells can contribute to CD4+ T-cell-mediated clearance of rotavirus in SCID mice.

Kushnir N, Bos NA, Zuercher AW, Coffin SE, Moser CA, Offit PA, Cebra JJ.

J Virol. 2001 Jun;75(12):5482-90.

44.

Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses.

Moser CA, Dolfi DV, Di Vietro ML, Heaton PA, Offit PA, Clark HF.

J Infect Dis. 2001 Apr 1;183(7):1108-11. Epub 2001 Mar 8.

PMID:
11237837
45.

Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria.

Brown KA, Kriss JA, Moser CA, Wenner WJ, Offit PA.

J Infect Dis. 2000 Oct;182(4):1039-43. Epub 2000 Sep 5.

PMID:
10979897
46.

Primary murine small intestinal epithelial cells, maintained in long-term culture, are susceptible to rotavirus infection.

Macartney KK, Baumgart DC, Carding SR, Brubaker JO, Offit PA.

J Virol. 2000 Jun;74(12):5597-603.

47.

Preventing harm from thimerosal in vaccines.

Offit PA.

JAMA. 2000 Apr 26;283(16):2104; author reply 2105. No abstract available.

PMID:
10791498
48.

A quantitative luminescence assay for measuring cell uptake of aqueous-based microcapsules in vitro.

Brubaker JO, Patil RT, Speaker TJ, Offit PA.

J Immunol Methods. 2000 Apr 3;237(1-2):85-93.

PMID:
10725454
49.

Immunologic methods and correlates of protection.

Macartney KK, Offit PA.

Methods Mol Med. 2000;34:119-32. doi: 10.1385/1-59259-078-0:119.

PMID:
21318858
50.

Supplemental Content

Loading ...
Support Center